T 1626/08 (Ramipril/SANOFI) of 05.12.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T162608.20121205
- Date of decision
- 5 December 2012
- Case number
- T 1626/08
- Online on
- 18 March 2013
- Petition for review of
- -
- Application number
- 00965906.1
- IPC class
- A61K 31/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Ramipril for the prevention of cardiovascular events
- Applicant name
- Sanofi-Aventis Deutschland GmbH
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Hexal AG
BOEHRINGER INGELHEIM Pharma GmbH & Co KG - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(3)European Patent Convention Art 123(2)
- Keywords
- Novelty (no): all features of claim 1 anticipated
Partly: added subject-matter (yes): features not originally disclosed - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.